Kolexia
Schneegans Olivier Endocrinologie
Schneegans Olivier
Endocrinologie
Centre Paul Strauss
Strasbourg, France
47 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la thyroïde Carcinomes Maladies de la thyroïde Carcinome neuroendocrine Carcinome papillaire Métastase tumorale Cancer papillaire de la thyroïde Récidive tumorale locale Tumeurs osseuses

Collaborateurs

Voir plus
Zerdoud Slimane
Zerdoud Slimane
Oncopole Toulouse, Toulouse, France
Bardet Stephane
Bardet Stephane
Centre François-Baclesse, Caen, France
Godbert Yann
Godbert Yann
Institut Bergonié, Bordeaux, France
Leboulleux Sophie
Leboulleux Sophie
Gustave-Roussy, Villejuif, France

Industries

Voir plus
Bayer
1 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Estimabl2 trial: Thyroidectomy without radioiodine in patients with low-risk thyroid cancer, 5 years of follow-up
39e congrès de la Société Française d'Endocrinologie 2023   01 octobre 2023
INTERMEDIATE: Multicentric Phase III Trial Comparing Two Strategies in Intermediate-risk Differentiated Thyroid Cancer Patients: Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up Based on Serum Tg Values and Diagnostic RAI Scintigraphy
Essai Clinique (Centre François-Baclesse)   06 septembre 2023
Correction: ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial.
Trials   11 juillet 2023
ESTIMABL3: ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer
Essai Clinique (Gustave-Roussy)   17 mai 2023
ESTIMABL2: Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
Essai Clinique (Gustave-Roussy)   16 mai 2023
ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial.
Trials   28 avril 2023
Thyrotoxicose à déclenchement tardif après arrêt de l’amiodarone : à propos d’un cas
9e Journées Francophones de Médecine nucléaire - Paris   01 mars 2023
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer.
The New England journal of medicine   23 mars 2022
Safety and Efficacy of Percutaneous Cryoablation of Extraspinal Thyroid Cancer Bone Metastases with Curative Intent: Single-Center Experience with a Median Follow-up of More than 5 Years.
Journal of vascular and interventional radiology : JVIR   19 mars 2022
LENVOS: A Prospective, Multicentre Phase II Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas (LENVOS)
Essai Clinique (Centre Léon-Bérard)   14 mars 2022